In the United States, colorectal cancer is the fourth most common cancer in men, after skin, prostate, and lung cancer. It is also the fourth most common cancer in women, after skin, lung, and breast cancer.
If you or someone you know has been diagnosed with colon or rectal cancer, it’s important to gather and learn as much information about the colorectal cancer as possible. New York Oncology Hematology is your resource for understanding the disease and the colorectal cancer treatment options that are available right here in New York’s Greater Capital Region.
If you receive a colon or rectal cancer diagnosis you’ll be referred to an oncologist who will plan your rectal or colon cancer treatment based on the stage of the cancer. The cancer specialist will assess the stage of your colon cancer based by ordering various tests. The various stages of rectal or colon cancer range from Stage 0 to Stage IV.
Based on the stage and other factors of your colorectal cancer, you and your cancer care team will discuss options for your treatment. Those options can include:
The oncologists at New York Oncology Hematology will help you decide on a plan that’s right for you.
You could be at risk of developing colorectal cancer if you have a family history of the disease.
Our Hereditary Cancer Risk Assessment team is here to guide you through cancer genetic counseling. Find out if you are at risk for hereditary colon cancer syndromes, and if you should take advantage of the Hereditary Cancer Risk Assessment program.
Local support groups, genetic risk testing, and financial counseling are just some of the areas the specialists at New York Oncology Hematology can assist you with during your colorectal cancer care.
We encourage you to learn more and take advantage of our cancer support groups and disease specific organizations, including the ColonCancer Alliance.